Does mirtazapine enhance serotonergic neurotransmission in depressed patients?
β Scribed by R. Whale; E. M. Clifford; P. J. Cowen
- Publisher
- Springer
- Year
- 2000
- Tongue
- English
- Weight
- 22 KB
- Volume
- 148
- Category
- Article
- ISSN
- 0033-3158
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Mirtazapine is a noradrenergic and specific serotonergic antidepressant (NaSSA) with a novel mode of action that differs from other antidepressants that are currently available. Clinical trials have demonstrated it to have good antidepressant efficacy and excellent tolerability. Analysis of the r
Results are reported from a randomized, double-blind, trazodone-and placebo-controlled, 6 weeks' eficacy and safety study of a new antidepressant Org 3770 (RemeronB), in 150 outpatients over 55 years of age, with a DSM 111 diagnosis of moderate to severe major depressive disorder. On the 21-item HAM
## Abstract ## Objective To evaluate the effect of mirtazapine augmentation in patients with sexual dysfunction induced by current selective serotonin reuptake inhibitor (SSRI) treatment. ## Methods Fortyβnine outpatients in remission from major depressive disorder with SSRI treatment and experi